0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover180.94%IV31.32%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.3649Delta0.1057Gamma10.88Leverage Ratio-0.0279Theta0.0014Rho3.97Eff Leverage0.0074Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$